213 related articles for article (PubMed ID: 26733611)
1. The Expression Quantitative Trait Loci in Immune Pathways and their Effect on Cutaneous Melanoma Prognosis.
Vogelsang M; Martinez CN; Rendleman J; Bapodra A; Malecek K; Romanchuk A; Kazlow E; Shapiro RL; Berman RS; Krogsgaard M; Osman I; Kirchhoff T
Clin Cancer Res; 2016 Jul; 22(13):3268-80. PubMed ID: 26733611
[TBL] [Abstract][Full Text] [Related]
2. Genetic associations of the interleukin locus at 1q32.1 with clinical outcomes of cutaneous melanoma.
Rendleman J; Vogelsang M; Bapodra A; Adaniel C; Silva I; Moogk D; Martinez CN; Fleming N; Shields J; Shapiro R; Berman R; Pavlick A; Polsky D; Shao Y; Osman I; Krogsgaard M; Kirchhoff T
J Med Genet; 2015 Apr; 52(4):231-9. PubMed ID: 25604082
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival.
Li B; Wang Y; Xu Y; Liu H; Bloomer W; Zhu D; Amos CI; Fang S; Lee JE; Li X; Han J; Wei Q
Int J Cancer; 2018 Jun; 142(11):2303-2312. PubMed ID: 29313974
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants in TKT and DERA in the nicotinamide adenine dinucleotide phosphate pathway predict melanoma survival.
Gu N; Dai W; Liu H; Ge J; Luo S; Cho E; Amos CI; Lee JE; Li X; Nan H; Yuan H; Wei Q
Eur J Cancer; 2020 Sep; 136():84-94. PubMed ID: 32659474
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants in glutamine metabolic pathway genes predict cutaneous melanoma-specific survival.
Chen K; Liu H; Liu Z; Bloomer W; Amos CI; Lee JE; Li X; Nan H; Wei Q
Mol Carcinog; 2019 Nov; 58(11):2091-2103. PubMed ID: 31435991
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants in PDSS1 and SLC16A6 of the ketone body metabolic pathway predict cutaneous melanoma-specific survival.
Dai W; Liu H; Chen K; Xu X; Qian D; Luo S; Amos CI; Lee JE; Li X; Nan H; Li C; Wei Q
Mol Carcinog; 2020 Jun; 59(6):640-650. PubMed ID: 32232919
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants in the genes encoding rho GTPases and related regulators predict cutaneous melanoma-specific survival.
Liu S; Wang Y; Xue W; Liu H; Xu Y; Shi Q; Wu W; Zhu D; Amos CI; Fang S; Lee JE; Hyslop T; Li Y; Han J; Wei Q
Int J Cancer; 2017 Aug; 141(4):721-730. PubMed ID: 28510328
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants in the integrin signaling pathway genes predict cutaneous melanoma survival.
Li H; Wang Y; Liu H; Shi Q; Xu Y; Wu W; Zhu D; Amos CI; Fang S; Lee JE; Han J; Wei Q
Int J Cancer; 2017 Mar; 140(6):1270-1279. PubMed ID: 27914105
[TBL] [Abstract][Full Text] [Related]
9. Melanoma risk loci as determinants of melanoma recurrence and survival.
Rendleman J; Shang S; Dominianni C; Shields JF; Scanlon P; Adaniel C; Desrichard A; Ma M; Shapiro R; Berman R; Pavlick A; Polsky D; Shao Y; Osman I; Kirchhoff T
J Transl Med; 2013 Nov; 11():279. PubMed ID: 24188633
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants in the calcium signaling pathway genes are associated with cutaneous melanoma-specific survival.
Wang X; Liu H; Xu Y; Xie J; Zhu D; Amos CI; Fang S; Lee JE; Li X; Nan H; Song Y; Wei Q
Carcinogenesis; 2019 Apr; 40(2):279-288. PubMed ID: 30596980
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome.
Garg K; Maurer M; Griss J; Brüggen MC; Wolf IH; Wagner C; Willi N; Mertz KD; Wagner SN
Hum Pathol; 2016 Aug; 54():157-64. PubMed ID: 27107457
[TBL] [Abstract][Full Text] [Related]
12. Cell-type-specific eQTL of primary melanocytes facilitates identification of melanoma susceptibility genes.
Zhang T; Choi J; Kovacs MA; Shi J; Xu M; ; ; Goldstein AM; Trower AJ; Bishop DT; Iles MM; Duffy DL; MacGregor S; Amundadottir LT; Law MH; Loftus SK; Pavan WJ; Brown KM
Genome Res; 2018 Nov; 28(11):1621-1635. PubMed ID: 30333196
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants in ELOVL2 and HSD17B12 predict melanoma-specific survival.
Dai W; Liu H; Xu X; Ge J; Luo S; Zhu D; Amos CI; Fang S; Lee JE; Li X; Nan H; Li C; Wei Q
Int J Cancer; 2019 Nov; 145(10):2619-2628. PubMed ID: 30734280
[TBL] [Abstract][Full Text] [Related]
14. Endometrial vezatin and its association with endometriosis risk.
Holdsworth-Carson SJ; Fung JN; Luong HT; Sapkota Y; Bowdler LM; Wallace L; Teh WT; Powell JE; Girling JE; Healey M; Montgomery GW; Rogers PA
Hum Reprod; 2016 May; 31(5):999-1013. PubMed ID: 27005890
[TBL] [Abstract][Full Text] [Related]
15. Characterization of expression quantitative trait loci in the human colon.
Singh T; Levine AP; Smith PJ; Smith AM; Segal AW; Barrett JC
Inflamm Bowel Dis; 2015 Feb; 21(2):251-6. PubMed ID: 25569741
[TBL] [Abstract][Full Text] [Related]
16. Functional Variants in Notch Pathway Genes NCOR2, NCSTN, and MAML2 Predict Survival of Patients with Cutaneous Melanoma.
Zhang W; Liu H; Liu Z; Zhu D; Amos CI; Fang S; Lee JE; Wei Q
Cancer Epidemiol Biomarkers Prev; 2015 Jul; 24(7):1101-10. PubMed ID: 25953768
[TBL] [Abstract][Full Text] [Related]
17. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.
Thomas NE; Edmiston SN; Alexander A; Groben PA; Parrish E; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; From L; Busam KJ; Hao H; Orlow I; Kanetsky PA; Luo L; Reiner AS; Paine S; Frank JS; Bramson JI; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Conway K;
JAMA Oncol; 2015 Jun; 1(3):359-68. PubMed ID: 26146664
[TBL] [Abstract][Full Text] [Related]
18. Expression quantitative trait loci (eQTL) mapping in Puerto Rican children.
Chen W; Brehm JM; Lin J; Wang T; Forno E; Acosta-Pérez E; Boutaoui N; Canino G; Celedón JC
PLoS One; 2015; 10(3):e0122464. PubMed ID: 25816334
[TBL] [Abstract][Full Text] [Related]
19. Genetic variants in the folate metabolic pathway genes predict cutaneous melanoma-specific survival.
Dai W; Liu H; Liu Y; Xu X; Qian D; Luo S; Cho E; Zhu D; Amos CI; Fang S; Lee JE; Li X; Nan H; Li C; Wei Q
Br J Dermatol; 2020 Oct; 183(4):719-728. PubMed ID: 31955403
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune genetic risk variants as germline biomarkers of response to melanoma immune-checkpoint inhibition.
Chat V; Ferguson R; Simpson D; Kazlow E; Lax R; Moran U; Pavlick A; Frederick D; Boland G; Sullivan R; Ribas A; Flaherty K; Osman I; Weber J; Kirchhoff T
Cancer Immunol Immunother; 2019 Jun; 68(6):897-905. PubMed ID: 30863922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
